JBC Connect with Cosmo for Collagen Detection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M312814200 on January 21, 2004

J. Biol. Chem., Vol. 279, Issue 14, 13402-13411, April 2, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/14/13402    most recent
M312814200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hensbergen, P. J.
Right arrow Articles by Tensen, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hensbergen, P. J.
Right arrow Articles by Tensen, C. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Furin Is a Chemokine-modifying Enzyme

IN VITRO AND IN VIVO PROCESSING OF CXCL10 GENERATES A C-TERMINALLY TRUNCATED CHEMOKINE RETAINING FULL ACTIVITY*

Paul J. Hensbergen{ddagger}, Dennis Verzijl§, Crina I. A. Balog¶, Remco Dijkman{ddagger}, Roel C. van der Schors||, Elizabeth M. H. van der Raaij-Helmer{ddagger}, Mariena J. A. van der Plas**, Rob Leurs§, André M. Deelder¶, Martine J. Smit§, and Cornelis P. Tensen{ddagger}{ddagger}{ddagger}

From the {ddagger}Department of Dermatology, Leiden University Medical Center, Wassenaarseweg 72, 2333 AL Leiden, the §Division of Medicinal Chemistry, Free University, De Boelelaan 1083, 1081 HV, Amsterdam, the Department of Parasitology, Leiden University Medical Center, P. O. Box 9600, 2300 RC, Leiden, the ||Department of Molecular Neurobiology, Free University, De Boelelaan 1087, 1081 HV, Amsterdam, and the **Department of Infectious Disease, Leiden University Medical Center, P. O. Box 9600, 2300 RC Leiden, The Netherlands

Chemokines comprise a class of structurally related proteins that are involved in many aspects of leukocyte migration under basal and inflammatory conditions. In addition to the large number of genes, limited processing of these proteins by a variety of enzymes enhances the complexity of the total spectrum of chemokine variants. We have recently shown that the native chemokine CXCL10 is processed at the C terminus, thereby shedding the last four amino acids. The present study was performed to elucidate the mechanism in vivo and in vitro and to study the biological activity of this novel isoform of CXCL10. Using a combination of protein purification and mass spectrometric techniques, we show that the production of C-terminally truncated CXCL10 by primary keratinocytes is inhibited in vivo by a specific inhibitor of pro-protein convertases (e.g. furin) but not by inhibition of matrix metalloproteinases. Moreover, CXCL10 is processed by furin in vitro, which is abrogated by a mutation in the furin recognition site. Using GTP{gamma}S binding, Ca2+ mobilization, and chemotaxis assays, we demonstrate that the C-terminally truncated CXCL10 variant is a potent ligand for CXCR3. Moreover, the inverse agonist activity on the virally encoded receptor ORF74 and the direct antibacterial activity of CXCL10 are fully retained. Hence, we have identified furin as a novel chemokine-modifying enzyme in vitro and most probably also in vivo, generating a C-terminally truncated CXCL10, which fully retains its (inverse) agonistic properties.


Received for publication, November 24, 2003 , and in revised form, January 7, 2004.

* This work was supported by Grants from the Dutch Cancer Society (RUL 2000-2168; to C. P. T.) and the Maurits and Anna de Kock Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger}{ddagger} To whom correspondence should be addressed: Leiden University Medical Center, Sylvius Laboratory, Department of Dermatology, Wassenaarseweg 72, 2333 AL Leiden, The Netherlands. Tel.: 31-71-5271903; Fax: 31-71-5271910; E-mail: C.P.Tensen{at}lumc.nl.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Exp. Med.Home page
P. Proost, T. Loos, A. Mortier, E. Schutyser, M. Gouwy, S. Noppen, C. Dillen, I. Ronsse, R. Conings, S. Struyf, et al.
Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation
J. Exp. Med., September 1, 2008; 205(9): 2085 - 2097.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. H. Cox, R. A. Dean, C. R. Roberts, and C. M. Overall
Matrix Metalloproteinase Processing of CXCL11/I-TAC Results in Loss of Chemoattractant Activity and Altered Glycosaminoglycan Binding
J. Biol. Chem., July 11, 2008; 283(28): 19389 - 19399.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Hasan, L. Mazzucchelli, M. Liebi, M. Lis, R. E. Hunger, A. Tester, C. M. Overall, and M. Wolf
Function of Liver Activation-Regulated Chemokine/CC Chemokine Ligand 20 Is Differently Affected by Cathepsin B and Cathepsin D Processing.
J. Immunol., June 1, 2006; 176(11): 6512 - 6522.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.